Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
Clinical Trial Site, Phoenix, Arizona Clinical Trial Site, Phoenix, Arizona Clinical Trial Site, New Haven, Connecticut Clinical Trial Site, Tampa, Florida Clinical Trial Site, Indianapolis, Indiana Clinical Trial Site, Grand Rapids, Michigan Clinical Trial Site, New York, New York Clinical Trial Site, New York, New York Clinical Trial Site, Huntersville, North Carolina Clinical Trial Site, Cleveland, Ohio Clinical Trial Site, Houston, Texas Clinical Trial Site, San Antonio, Texas Clinical Trial Site, Salt Lake City, Utah Clinical Trial Site, Fairfax, Virginia